NEWS

2025

• 2025.8.29
  • PHC Corporation’s Biomedical Division Wins 2025 R&D 100 Award for LiCellMo® Live Cell Metabolic Pathway Analyzer
• 2025.7.1
  • PHC Announces Exclusive Distribution of MaxCyte® ExPERT™ Platform in Japan – Enabling Scalable, Non-Viral Cell Engineering for Research, Biomanufacturing, and Therapeutic Development –
• 2025.3.19
  • PHC and Cyfuse Develop Innovative Production Technology for the Commercialization of 3D Cell Products
• 2025.2.10
  • PHC and CCRM Collaborate to Develop Primary T-Cell Expansion Culture Processes to Enhance Efficiency and Improve Cell Quality